Zheng Quan Zhi Xing·2025-08-06 16:22Core Viewpoint - The company, BeiGene, has voluntarily disclosed an adjustment to its 2025 operating performance forecast, indicating a positive outlook driven by market expansion and improved product mix [1]. Group 1: Adjusted Performance Forecast - The adjusted revenue forecast for 2025 is now between RMB 35.8 billion and RMB 38.1 billion, up from the previous estimate of RMB 35.2 billion to RMB 38.1 billion [1]. - Research and development expenses, along with sales and management costs, remain unchanged, projected between RMB 29.5 billion and RMB 31.9 billion [1]. - The gross profit margin is expected to be in the higher range of 80% to 90%, reflecting improvements in product mix and production efficiency [1]. Group 2: Reasons for Adjustment - The increase in revenue expectations is attributed to BeiGene's leading position in the U.S. market and ongoing expansion in Europe and other key global markets [1]. - The anticipated improvement in gross margin is primarily due to enhancements in product mix and production efficiency [1].